FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Industries

  • Medicine ‎5
    • Pharmaceuticals ‎5

Contact Info

Location

Teligene

  • 5Product
  • 1Types
  • 1Industry

About Company

Established in 2011, Teligene is a drug discovery company located in Suzhou BioBay, dedicating to developing innovative small-molecule drugs. We have a pipeline of candidate molecules with potential advantages over existing therapeutics that are aimed at improving patient outcomes in conditions with significant unmet medical need. Our mission: We are dedicating to design and develop novel small molecule drugs to improve quality of life. Our focus: We are

Established in 2011, Teligene is a drug discovery company located in Suzhou BioBay, dedicating to developing innovative small-molecule drugs. We have a pipeline of candidate molecules with potential advantages over existing therapeutics that are aimed at improving patient outcomes in conditions with significant unmet medical need. Our mission: We are dedicating to design and develop novel small molecule drugs to improve quality of life. Our focus: We are concentrating our effects on cancer therapy, which is one of the areas of greatest unmet need. Our strength: We have embedded knowledge in key areas of the drug discovery process and utilize a highly sophisticated and effective combination of computational and structural approaches to drug design and optimization.

Products

HDAC inhibitor

MEDICINE - PHARMACEUTICALS   |  ANTINEOPLASTIC AGENT

HDAC inhibitor

Application :

Cancer therapies
HERS inhibitor

MEDICINE - PHARMACEUTICALS   |  ANTINEOPLASTIC AGENT

HERS inhibitor

Application :

Cancer therapies
EGFR inhibitor

MEDICINE - PHARMACEUTICALS   |  ANTINEOPLASTIC AGENT

EGFR inhibitor

Application :

Cancer therapies
ALK inhibitor

MEDICINE - PHARMACEUTICALS   |  ANTINEOPLASTIC AGENT

ALK inhibitor

Application :

Cancer therapies
BRAF inhibitor

MEDICINE - PHARMACEUTICALS   |  ANTINEOPLASTIC AGENT

BRAF inhibitor

Application :

Cancer therapies

Analytical Reports